Search

Your search keyword '"Manfredi, S."' showing total 243 results

Search Constraints

Start Over You searched for: Author "Manfredi, S." Remove constraint Author: "Manfredi, S." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
243 results on '"Manfredi, S."'

Search Results

2. Abstract No. 257 ▪ FEATURED ABSTRACT The PROACTIF French Registry Study of Y-90 Glass Microspheres for the Treatment of Liver Malignancies: Interim Analysis of 670 Hepatocellular Carcinoma (HCC) Patients

6. Emphysematous cystitis: review of current literature, diagnosis and management challenges

7. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

8. Nursing schools and academic health centers: toward improved alignment and a synergistic partnership

10. LBA28 Prognostic effect of imaging and CEA follow-up in resected colorectal cancer (CRC): Final results and relapse free survival (RFS) - PRODIGE 13 a FFCD phase III trial

12. Inguinal Hernia: Mesh Fixation

13. Parastomal Hernia, Risky Zone & Prophilactic Mesh

16. Classical and Modern Standard Arabic

17. 481P Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer

19. Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis

20. Creative connectivity project – A network based approach to understand correlations between interdisciplinary group dynamics and creative performance

22. Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia

23. 522TiP PRODIGE 71 - BEVAMAINT: A randomized phase III study comparing maintenance treatment with fluoropyrimidine + bevacizumab versus fluoropyrimidine after induction chemotherapy for a metastatic colorectal cancer

24. 52P Modified FOLFIRINOX versus CISGEM as first-line chemotherapy for advanced biliary tract cancer: Results of AMEBICA PRODIGE 38 randomized phase II trial

25. 398O Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer (CRC) - PRODIGE 13 a FFCD phase III trial

26. Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

29. Effect of a commercially available fish-based dog food enriched with nutraceuticals on hip and elbow dysplasia in growing Labrador retrievers

34. ARCAD-NADEGE cohort: Result of a small bowel adenocarcinomas prospective cohort

36. 609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

37. 773TiPPRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

38. Reflexiones acerca de los 500 años de Historia de Brasil. Confines políticos y relaciones interétnicas

39. Results of the Phase II randomized French trial PRODIGE 21 comparing sorafenib vs pravastatin vs sorafenib and pravastatin vs best supportive care for the palliative treatment of HCC in CHILD B cirrhotic patients

42. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

43. 842TiP - Nal-iri/lv5-fu versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI-PRODIGE 62): A FFCD multicenter, randomized, phase II study

44. PRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

45. PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma

47. PO-0702: Phase I trial evaluating panitumumab in combination with chemoradiotherapy for anal cancers

50. Cholecystocutaneous fistula containing multiple gallstones in a dog

Catalog

Books, media, physical & digital resources